title: Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery.
abstract: Changes in the number of alveolar macrophages were correlated with organism burden during Pneumocystis carinii infection. The lungs of healthy, dexamethasone-treated, and dexamethasone-treated and P. carinii-infected rats were lavaged with phosphate-buffered saline. Counting of alveolar macrophages in the lavage fluids revealed that P. carinii infection caused a 58% decrease in the number of alveolar macrophages and that higher P. carinii organism burdens caused a more rapid decrease in alveolar macrophage number. As a control, healthy rats were challenged with the same number of organisms as that normally used to generate P. carinii infections in dexamethasone-treated rats. Thirteen days after challenge, these rats had a profound (54%) increase in alveolar macrophage number in response to the challenge, while the number of alveolar macrophages in immunosuppressed and P. carinii-infected rats had decreased significantly by this time point. These experiments created the first animal model to mimic human pneumocystis pneumonia in alveolar macrophage number alterations. Reduction of P. carinii organism numbers by treatment of rats with trimethoprim and sulfamethoxazole brought a slow rebound in alveolar macrophage number, while recovery from P. carinii infection by cessation of immunosuppression brought a rapid rebound in alveolar macrophage number. These results suggest that both the immune state of the host and P. carinii burden affect alveolar macrophage number.
authors.affiliation: Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. melasbur@iupui.edu
authors.forename: Mark E
authors.initials: ME
authors.lastname: Lasbury
authors.forename: Pamela J
authors.initials: PJ
authors.lastname: Durant
authors.forename: Marilyn S
authors.initials: MS
authors.lastname: Bartlett
authors.forename: James W
authors.initials: JW
authors.lastname: Smith
authors.forename: Chao-Hung
authors.initials: CH
authors.lastname: Lee
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology / Q000276:immunology; D002452:Cell Count; D003907:Dexamethasone / Q000494:pharmacology; D005260:Female; D005938:Glucocorticoids / Q000494:pharmacology; D008168:Lung / Q000276:immunology; D016676:Macrophages, Alveolar / Q000166:cytology / Q000276:immunology* / Q000382:microbiology; D011010:Pneumocystis / Q000254:growth & development*; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy / Q000276:immunology* / Q000382:microbiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000494:pharmacology
chemical_list: D000890:Anti-Infective Agents; D005938:Glucocorticoids; D003907:Dexamethasone; D015662:Trimethoprim, Sulfamethoxazole Drug Combination